3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Sarcoma, Ewing
1
Prostate Adenocarcinoma
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Male Urogenital Diseases
1
Female Urogenital Diseases
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
fludarabine
2
durvalumab
2
Gemcitabine
2
Cyclophosphamide
2
Cisplatin
2
trastuzumab deruxtecan
1
tivozanib
1
guadecitabine
1
atezolizumab
1
Taxes
1
Specimen Handling
1
S 1 (combination)
1
Platinum
1
Oxaliplatin
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Ipilimumab
1
Folfox protocol
1
Fluorouracil
1
Capecitabine
1
CTLA-4 Antigen
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Radiation Dose Hypofractionation
×
30 days
×
Clear all
No trials found.